Page last updated: 2024-08-22

2-amino-1,3,4-thiadiazole and Liver Neoplasms

2-amino-1,3,4-thiadiazole has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Block, TM; Cuconati, A; Goddard, C; Guo, H; Mills, C; Xu, X; Yu, W; Zhang, X	1

Other Studies

1 other study(ies) available for 2-amino-1,3,4-thiadiazole and Liver Neoplasms

Article	Year
Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells. PloS one, 2013, Volume: 8, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Multiprotein Complexes; Phosphorylation; Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction; Thiadiazoles; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2013

Article

Year

Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells.

PloS one, 2013, Volume: 8, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Multiprotein Complexes; Phosphorylation; Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction; Thiadiazoles; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2013